AOD9604 ™
$150.00 Original price was: $150.00.$142.00Current price is: $142.00.
AOD9604 ™ is a synthetic peptide fragment of human growth hormone (HGH), specifically derived from amino acids 176‑191. It was developed to target fat metabolism and weight management without stimulating growth hormone activity.
What Is Neuro Labs AOD9604™?
AOD9604™ is a modified peptide fragment of HGH:
- Stimulates lipolysis (fat breakdown).
- Inhibits lipogenesis (fat formation).
- Studied for weight management and metabolic health.
- Explored in anti‑obesity and longevity research.
Description
AOD9604 ™
AOD9604 ™ is a synthetic peptide fragment of human growth hormone (HGH), specifically derived from amino acids 176‑191. It was developed to target fat metabolism and weight management without stimulating growth hormone activity.
What Is Neuro Labs AOD9604™?
AOD9604™ is a modified peptide fragment of HGH:
- Stimulates lipolysis (fat breakdown).
- Inhibits lipogenesis (fat formation).
- Studied for weight management and metabolic health.
- Explored in anti‑obesity and longevity research.
Key Features
- HGH fragment 176‑191.
- Fat metabolism support.
- Weight management.
- Non‑GH stimulating.
- Anti‑obesity research.
How Does AOD9604™ Work?
- Mimics the lipolytic region of HGH.
- Enhances fat oxidation and metabolism.
- Reduces fat accumulation in adipose tissue.
- Does not stimulate IGF‑1 or growth hormone pathways.
Benefits of Neuro Labs AOD9604™
Clinical & Research Benefits
- Fat loss: Promotes breakdown of stored fat.
- Weight management: Studied for obesity treatment.
- Metabolic health: Improves lipid metabolism.
- Longevity research: Supports healthy aging via metabolic pathways.
Lifestyle & Wellness Benefits
- Body composition: Helps reduce fat mass.
- Energy balance: Enhances fat utilization for energy.
- Non‑stimulant: Does not affect growth hormone or IGF‑1.
Forms of AOD9604™
- Injectable peptide → Most common in research.
- Oral capsules → Studied for bioavailability.
- Topical creams → Explored for localized fat reduction.
📊 Comparison – AOD9604™ vs HGH
| Feature | AOD9604™ | HGH |
|---|---|---|
| Type | Synthetic peptide fragment (176‑191) | Full growth hormone |
| Mechanism | Stimulates fat metabolism only | Stimulates growth, IGF‑1, metabolism |
| Benefits | Fat loss, weight management | Growth, metabolism, anti‑aging |
| Risks | Minimal, non‑GH stimulating | Potential IGF‑1 stimulation, side effects |
| Unique Advantage | Targets fat metabolism without GH activity | Broad systemic effects |
⚠️ Possible Side Effects and Precautions
- Mild digestive discomfort.
- Rare reports of headache or fatigue.
- Limited availability outside research contexts.
- Should not replace prescribed medical therapies.
📊 Comparison Chart – AOD9604™ vs Other Fat‑Loss Peptides
Here’s a structured side‑by‑side comparison of AOD9604™ with other fat‑loss peptides: CJC‑1295, Tesamorelin, and Fragment 176‑191.
| Feature | AOD9604™ | CJC‑1295 | Tesamorelin | Fragment 176‑191 |
|---|---|---|---|---|
| Origin | Synthetic fragment of HGH (176‑191) | GHRH analog with DAC modification | GHRH analog approved for HIV lipodystrophy | Natural HGH fragment (176‑191) |
| Primary Role | Fat metabolism, weight management | Sustained GH release, anti‑aging | Reduces visceral fat, metabolic health | Fat loss, similar to AOD9604 |
| Mechanism | Stimulates lipolysis, inhibits lipogenesis | Stimulates pituitary GH release over time | Stimulates GH release → IGF‑1 → fat reduction | Directly enhances fat metabolism |
| Clinical Benefits | Fat loss without GH stimulation | Longevity research, continuous GH support | FDA‑approved for HIV‑related fat reduction | Fat loss, metabolic support |
| Lifestyle Benefits | Weight management, body composition | Anti‑aging, vitality, recovery | Targeted fat loss, improved metabolism | Fat burning, body composition |
| Unique Advantage | Targets fat metabolism only, no GH effects | Long half‑life, sustained GH activity | Clinically approved for specific fat reduction | Natural fragment, overlaps with AOD9604 |
AOD9604™ is a specialized HGH fragment designed to promote fat metabolism without stimulating growth hormone pathways. CJC‑1295 focuses on sustained GH release, Tesamorelin is clinically approved for visceral fat reduction in HIV patients, and Fragment 176‑191 is the natural HGH sequence that inspired AOD9604.
Together, these peptides highlight different strategies in fat loss and metabolic research: AOD9604™ offers targeted fat metabolism, CJC‑1295 provides longevity and GH support, Tesamorelin delivers clinical fat reduction, and Fragment 176‑191 represents the natural foundation of fat‑burning peptides.
AOD9604 ™ Frequently Asked Questions:
- What is AOD9604™? A peptide fragment of HGH studied for fat metabolism.
- Is AOD9604™ safe? Generally considered safe in research doses.
- Does AOD9604™ build muscle? No, it targets fat metabolism only.
- Is AOD9604™ FDA approved? Not approved for medical use; marketed as a research peptide.
- How is AOD9604™ different from HGH? It is a fragment that stimulates fat metabolism without GH activity.
📌 Long Conclusion
The AOD9604™ peptide is a breakthrough in metabolic and anti‑obesity research. By mimicking the fat‑burning region of HGH without stimulating growth hormone pathways, it offers a targeted approach to fat loss and weight management.
Its unique ability to promote lipolysis, inhibit lipogenesis, and improve metabolic health makes AOD9604™ a promising candidate in longevity and wellness science. With lab‑tested purity, non‑GMO formulation, and diverse applications, AOD9604™ is not just another peptide—it is a specialized tool for studying fat metabolism and healthy aging.

